KIORA PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
  • Kiora Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 4.21M shares, a 434% increase year-over-year.
  • Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.84M shares, a 561% increase from 2022.
  • Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 732K shares, a 204% increase from 2021.
  • Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 241K shares, a 94.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 4.84M +4.11M +561% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 732K +491K +204% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 241K -4.35M -94.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 4.59M Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.